| 标题 |
1066P Final results from the ENGOT-Ov41/GEICO 69-O/ANITA randomised phase III trial of atezolizumab (atezo), platinum-based chemotherapy (CT) and maintenance niraparib (nira) for late-relapsing recurrent ovarian cancer (rOC) |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |